GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Gross Margin %

Biovica International AB (OSTO:BIOVIC B) Gross Margin % : 71.81% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Biovica International AB's Gross Profit for the three months ended in Jan. 2024 was kr0.77 Mil. Biovica International AB's Revenue for the three months ended in Jan. 2024 was kr1.08 Mil. Therefore, Biovica International AB's Gross Margin % for the quarter that ended in Jan. 2024 was 71.81%.

Warning Sign:

Biovica International AB gross margin has been in long-term decline. The average rate of decline per year is -14.3%.


The historical rank and industry rank for Biovica International AB's Gross Margin % or its related term are showing as below:

OSTO:BIOVIC B' s Gross Margin % Range Over the Past 10 Years
Min: 113.43   Med: 287.42   Max: 898.69
Current: 113.43


During the past 9 years, the highest Gross Margin % of Biovica International AB was 898.69%. The lowest was 113.43%. And the median was 287.42%.

OSTO:BIOVIC B's Gross Margin % is ranked better than
98.53% of 749 companies
in the Biotechnology industry
Industry Median: 60.63 vs OSTO:BIOVIC B: 113.43

Biovica International AB had a gross margin of 71.81% for the quarter that ended in Jan. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Biovica International AB was -14.30% per year.


Biovica International AB Gross Margin % Historical Data

The historical data trend for Biovica International AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Gross Margin % Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only 287.42 507.84 253.73 228.17 136.44

Biovica International AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 114.58 164.92 125.94 103.20 71.81

Competitive Comparison of Biovica International AB's Gross Margin %

For the Biotechnology subindustry, Biovica International AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Gross Margin % falls into.



Biovica International AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Biovica International AB's Gross Margin for the fiscal year that ended in Apr. 2023 is calculated as

Gross Margin % (A: Apr. 2023 )=Gross Profit (A: Apr. 2023 ) / Revenue (A: Apr. 2023 )
=4.6 / 3.384
=(Revenue - Cost of Goods Sold) / Revenue
=(3.384 - -1.233) / 3.384
=136.44 %

Biovica International AB's Gross Margin for the quarter that ended in Jan. 2024 is calculated as


Gross Margin % (Q: Jan. 2024 )=Gross Profit (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=0.8 / 1.075
=(Revenue - Cost of Goods Sold) / Revenue
=(1.075 - 0.303) / 1.075
=71.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Biovica International AB  (OSTO:BIOVIC B) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Biovica International AB had a gross margin of 71.81% for the quarter that ended in Jan. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Biovica International AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB (OSTO:BIOVIC B) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines